Mitumomab
CAS No:
216503-58-1
Order 216503-58-1
mitumomab
56875-00-4
3-Pyrazolidinone, 4,4-difluoro-5-hydroxy-1,5-dimethyl-2-phenyl-
56878-33-2
tetrasodium 7,7-(carbonyldiimino)bis[4-hydroxy-3-[(4-sulphonatophenyl)azo]naphthalene-2-sulphonate]
21653-18-9
(-)-3-Neothujol
56875-60-6
2-Naphthalenesulfonyl chloride, 7-methoxy-
5687-86-5
Cyclopropanecarboxamide,N-hydroxy-
5687-84-3
Cyclopropanebutanoic acid
56879-35-7
6,10,14,18,22,26,30,34,38,42-Tetratetracontadecaen-1-ol,3,7,11,15,19,23,27,31,35,39,43-undecamethyl-, dihydrogen phosphate
216530-78-8
1H-Indole-2-carboxaldehyde, 1-acetyl-
56879-12-0
Ethanone, 1-[2-methoxy-4-(phenylmethoxy)phenyl]-
56876-28-9
4-[2-amino-2-(2H-tetrazol-5-yl)ethyl]phenol
56875-57-1
1-Naphthalenesulfonyl chloride, 5-(acetyloxy)-
2165-08-4
2H-Naphth[1,2-d]imidazol-2-one, 1,3-dihydro-, hydrazone
216506-68-2
Pyridine, 2-fluoro-4-[3-(4-fluorophenyl)-1H-pyrazol-4-yl]-
568-76-3
gamma-hydroxyphenylbutazone
56878-16-1
5'-Adenylic acid, 8-[(3-amino-2-hydroxypropyl)amino]-
21650-54-4
Diazene, bis(4-methylphenyl)-, (1E)-
216503-58-1
Mitumomab
56875-76-4
1-butyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylic acid
56879-10-8
Phosphine oxide,[(2,4,6-trimethyl-1,3,5-benzenetriyl)tris(methylene)]tris[diphenyl-
56878-32-1
tetrasodium 7,7-(carbonyldiimino)bis[4-hydroxy-3-[(2-methoxy-4-sulphonatophenyl)azo]naphthalene-2-sulphonate]
Order
2438-80-4
6-deoxy-L-Galactose L-(-)-FUCOSE
Order
302-95-4
Sodium deoxycholate